Genetic variants of SLC28A3 are associated with increased risk of anthracycline‐induced cardiomyopathy [http://www.ncbi.nlm.nih.gov/pubmed/30351207?dopt=AbstractPlus]. Here, SLC28A3 is linked to cardiomyopathy.